Stock Price
2.16
Daily Change
-0.03 -1.37%
Monthly
-51.89%
Yearly
-22.86%
Q2 Forecast
2.12

Acasti Pharma reported $-2.53M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Acasti Pharma USD -2.53M 560K Sep/2025
Addus HomeCare USD 34.07M 8.2M Mar/2026
Amarin USD -2.26M 564K Dec/2025
Cassava Sciences USD -13.55M 1.69M Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Option Care Health USD 72.54M 18.96M Mar/2026
Organigram Holdings CAD -20.13M 7.92M Dec/2025
Tilray USD -20.01M 9.34M Sep/2025